Understanding Cancer: Expanding the Horizon Through Applying the Collective Wisdom of Ayurveda and Conventional Medicine

  • Sanjeev Rastogi
  • Sen Pathak
  • Ram Harsh Singh


Despite much advancement in its understanding, cancer is still one among the leading causes of death. Poor prognosis of cancer is primarily attributed to its silent course of pathogenesis not allowing any prediction about impending threats unless it becomes clinically obvious. Unfortunately, this obviousness in cancer appears very late and hence leaves little room to act effectively afterward. Early diagnosis therefore is crucial from the prognostic perspectives of cancer. Cancer prevention is equally difficult in most conditions barring few, for lack of clearly attributable causes with oncogenesis. Seeing the pervasive presence of cancer, this may be hypothesized that the cause of cancer must be related closely to our lifestyles and environmental exposures. Ayurveda, an ancient health-care wisdom from the Orient, presents its own biological principles to understand the cause of disease and health. It identifies various generic and specific attributes leading to the state of health and disease. Following the right path, one can choose to remain healthy and even can revert to health if a disease has arrived due to some deviations from the recommended path of healthy living. These principles of health and disease are ipso facto applicable to every disease including cancer.

This chapter presents a comprehensive view of general principles of health proposed by Ayurveda and attempts to see their applicability in the field of cancer treatment and prevention. This attempt, however, is made essentially in tune to see the translational appeal of various Ayurvedic principles referring to the field eventually to enrich the contemporary understanding about cancer and also to know what best can be done through a collective wisdom of Ayurveda and modern health care in the field of oncogenesis.


Cancer Oncogenesis Ayurveda Cancer prevention Cancer diagnosis 


  1. 1.
    Cancer, Fact sheet, February 2017. Last accessed on 12 Nov 2017.
  2. 2.
    Singh RH. Perspectives in innovation in the AYUSH sector. J Ayurveda Integr Med. 2011;2(2):52–4. Scholar
  3. 3.
    Union for International Cancer Control. The economics of cancer prevention and control. Data digest. Published 2014. Accessed 4 Feb 2015.
  4. 4.
    Carter AJ, Nguyen CN. A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding. BMC Public Health. 2012;12:526. Scholar
  5. 5.
    Mile stones in Cancer research and discovery. Last accessed on 15 Nov 2017.
  6. 6.
    Govindarajan V, Trimble C. Reverse innovation: create far from home win everywhere. Boston: Harward University Press; 2012.Google Scholar
  7. 7.
    Lancet. Water with sugar and salt. Lancet 1978;312:300–1 (Originally published as Volume 2, 300–301, 1978). [PubMed].Google Scholar
  8. 8.
    Rahaman MM, Aziz KM, Patwari Y, et al. Diarrhoeal mortality in two Bangladeshi villages with and without community-based oral rehydration therapy. Lancet. 1979;2:809–12. [PubMed].CrossRefGoogle Scholar
  9. 9.
    Patwardhan B, Vaidya ADB, Chorghade M, Joshi SP. Reverse pharmacology and systems approaches for drug discovery and development. Curr Bioactive Comp. 2008;4:201–12.CrossRefGoogle Scholar
  10. 10.
    Gupta AK. Grass roots innovation. New Delhi: Penguin Random House India; 2016.Google Scholar
  11. 11.
    Fridlender M, Kapulnik Y, Koltai H. Plant derived substances with anti-cancer activity: from folklore to practice. Front Plant Sci. 2015;6:799. Scholar
  12. 12.
    Swyngedouw E. Globalisation or ‘glocalisation’? Networks, territories and rescaling. Camb Rev Int Aff. 2004;17(1):25–48.CrossRefGoogle Scholar
  13. 13.
    Hawking S. On the shoulders of giants. The great works of physics and astronomy (Running Press 2002). ISBN 0-7624-1698-X.
  14. 14.
  15. 15.
    Cancer Prev. Last accessed on 9 Mar 2018.
  16. 16.
    Sloan FA, Gelband H, editors. Cancer control opportunities in low- and middle-income countries. Institute of Medicine (US) Committee on Cancer Control in Low- and Middle-Income Countries. Washington, DC: National Academies Press (US); 2007.Google Scholar
  17. 17.
    Al-Azri MH. Delay in Cancer diagnosis: causes and possible solutions. Oman Med J. 2016;31(5):325–6. Scholar
  18. 18.
    Ahmad AS, Ormiston-Smith N, Saseini PD. Trends in the life time risk of developing cancer in great Britain: comparison of risk for those born from 1930 to 1960. Br J Cancer. 2015;112:943–7. Scholar
  19. 19.
    Ghodke Y, Joshi K, Patwardhan B. Traditional medicine to modern pharmacogenomics: Ayurveda Prakriti type and CYP2C19 gene polymorphism associated with the metabolic variability. Evid Based Complement Alternat Med. 2011;2011(249528):1.CrossRefGoogle Scholar
  20. 20.
    Aggarwal S, Negi S, Jha P, Singh PK, Stobdan T, Pasha MA. Indian genome variation consortium. EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda. Proc Natl Acad Sci U S A. 2010;107:18961–6.CrossRefGoogle Scholar
  21. 21.
    Akoury D. Epigenetics effects of stress influence the genomics, proteomics, metabolomics of addiction and cancer pathways. Adv Genet Eng. 2015;4:122. Scholar
  22. 22.
    Valiathan MS. Ayurvedic Biology: a decadal vision document. Bengaluru: Indian Academy of Science; 2006.Google Scholar
  23. 23.
    Rastogi S. Ayurvedic principles of food and nutrition: translating the theory into evidence based practice. In: Rastogi S, editor. Ayurvedic science of food and nutrition. New York: Springer; 2014.CrossRefGoogle Scholar
  24. 24.
    Szymanski J, Jozefczuk S, Nikoloski Z, et al. Stability of metabolic correlations under changing environmental conditions in Escherichia coli—a systems approach. PLoS One. 2009;4(10):e7441. CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Vousden KH, Xin L. Live or let die: the cell’s response to p53. Nat Rev Cancer. 2002;2:594–604. Scholar
  26. 26.
    Hamada N, Kodama S, Suzuki K, Watanabe M. Gap junctional intercellular communication and cellular response to heat stress. Carcinogenesis. 2003;24(11):1723–8. Epub 2003 Aug 14.CrossRefGoogle Scholar
  27. 27.
    Garg P. Awareness that early cancer lump is painless could decrease breast cancer mortality in developing countries. World J Clin Oncol. 2016;7(3):321–3. Scholar
  28. 28.
    Hoang JK, Lee WK, Lee M, Johnson D, Farrell S. US features of thyroid malignancy: pearls and pitfalls. Radio Graphics. 2007;27:847–65.Google Scholar
  29. 29.
    Rastogi S, editor. Ayurvedic science of food and nutrition. NewYork: Springer; 2014.Google Scholar
  30. 30.
    Smetana K, Lacina L, Szabo P, Dvorankova B, Broz P, Sedo A. Ageing as an important risk factor for cancer. Anticancer Res. 2016;36(10):5009–17.CrossRefGoogle Scholar
  31. 31.
    White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ. Age and cancer risk: a potentially modifiable relationship. Am J Prev Med. 2014;46(3 Suppl 1):S7–15. Scholar
  32. 32.
    Pathak S, Multani AS. Aneuploidy, stem cells and cancer. In: Bignold LP, editor. Cancer: cell structure, carcinogens and genomic instability. Cham: Birkhauser Verlag; 2006. p. 49–64.CrossRefGoogle Scholar
  33. 33.
    Singh RH. Reverse innovation and translational studies in AYUSH. Ann Ayurvedic Med. 2012;1(1–2):2–3.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Sanjeev Rastogi
    • 1
  • Sen Pathak
    • 2
  • Ram Harsh Singh
    • 3
  1. 1.Department of Kaya ChikitsaState Ayurvedic College and Hospital, Lucknow UniversityLucknowIndia
  2. 2.Department of Genetics/Cancer BiologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  3. 3.Department of Kaya Chikitsa, Faculty of Ayurveda, Institute of Medical SciencesBanaras Hindu UniversityVaranasiIndia

Personalised recommendations